SCHEDULE: CapsoVision Schedule 13G Filing Amendment
Beneficial Ownership Filing
Several entities and individuals have filed an amendment to their Schedule 13G, reporting 0% beneficial ownership of CapsoVision, Inc. common stock as of March 31, 2026.
Summary
- This filing is an amendment (Amendment No. 1) to a Schedule 13G, which is a filing required for beneficial owners of more than 5% of a class of registered equity securities.
- The reporting persons include CID Greater China Venture Capital Fund III, L.P., CID Venture Capital General Partner III, Limited, Altenza International Limited, Ching Yi Chang, and Chih Cheng Chang.
- As of March 31, 2026, the "event which requires filing of this statement" is noted.
- All reporting persons state they have 0.00 shares beneficially owned, representing 0% of the class of securities.
- This indicates that none of the listed reporting persons hold any shares in CapsoVision, Inc. as of the filing date.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this filing as having a neutral to slightly negative sentiment due to the complete absence of reported beneficial ownership, indicating no current investment interest from the reporting entities.
Negatives
- The filing indicates that the reporting persons collectively hold 0% of CapsoVision, Inc.'s common stock, suggesting no significant investment or control by these entities.
Future Outlook
No forward-looking statements or guidance are provided in this filing.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are routine disclosures for significant institutional investors. The absence of any reported beneficial ownership by these entities suggests they are not currently significant holders of CapsoVision, Inc. stock.
Stakeholder Impact
- Shareholders: The filing provides no indication of new investment or changes in significant holdings by these entities, thus likely having minimal immediate impact on share price or perception.
Key Dates
| Date | Description |
|---|---|
| 03/31/2026 | Date of event which requires filing of this statement. |
| 04/07/2026 | Date of signatures for the filing. |
Keywords
Schedule 13G, CapsoVision, Inc., Beneficial Ownership, SEC Filing, Amendment, Equity Securities, Venture Capital
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.